Levodopa + Benserazide

Levodopa + Benserazide
Product Description

tablets 100/25 mg, 200/50 mgcapsules 50/12.5 mg, 100/25 mg, 200/50 mg
dispersible tablets 50/12.5 mg, 100/25 mg, 200/50 mg

Rivopharm SA

  • Country/Region:
    Switzerland
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator

Rivopharm SA

  • Country/Region:
    Switzerland
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator

More Products from Rivopharm SA (30)